What is the official website of Galderma ?

The official website of Galderma is http://www.galderma.com.

What is Galderma's cybersecurity risk score?

Galderma has an AI-generated cybersecurity risk score of 810 out of 1000, indicating a Good security posture according to Rankiteo's assessment.

How many security incidents has Galderma experienced?

According to Rankiteo, Galderma currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Galderma been affected by any supply chain cyber incidents ?

According to Rankiteo, Galderma has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Galderma have SOC 2 Type 1 certification ?

According to Rankiteo, Galderma is not certified under SOC 2 Type 1.

Does Galderma have SOC 2 Type 2 certification ?

According to Rankiteo, Galderma does not hold a SOC 2 Type 2 certification.

Does Galderma comply with GDPR ?

According to Rankiteo, Galderma is not listed as GDPR compliant.

Does Galderma have PCI DSS certification ?

According to Rankiteo, Galderma does not currently maintain PCI DSS compliance.

Does Galderma comply with HIPAA ?

According to Rankiteo, Galderma is not compliant with HIPAA regulations.

Does Galderma have ISO 27001 certification ?

According to Rankiteo,Galderma is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Galderma operate in ?

Galderma operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Galderma have ?

Galderma employs approximately 8,474 people worldwide.

Does Galderma own any subsidiaries ?

Galderma presently has no subsidiaries across any sectors.

How many LinkedIn followers does Galderma have ?

Galderma's official LinkedIn profile has approximately 506,555 followers.

What is the NAICS classification code for Galderma ?

Galderma is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Galderma have a Crunchbase profile ?

No, Galderma does not have a profile on Crunchbase.

Does Galderma have a LinkedIn profile ?

Yes, Galderma maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/galderma-.

How many cybersecurity incidents has Galderma experienced ?

As of July 30, 2026, Rankiteo reports that Galderma has not experienced any cybersecurity incidents.

How many peer or competitor companies does Galderma have ?

Galderma has an estimated 5,712 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Galderma

Boost Score +25 with badge (5 left)

810

/1000

Good

835

/1000

Good

Galderma Vendor Cyber Rating & Cyber Score

galderma.com

Add Your Compliance Badge

Galderma is the leading company solely dedicated to skin and advancing the future of dermatology. We deliver an innovative, science-based portfolio of sophisticated brands and services across Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Through trusted partnerships with healthcare professionals, we ensure to meet individual consumer and patient needs with superior outcomes.

Galderma A.I CyberSecurity Scoring

Scoring History

Galderma

Galderma CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

Galderma Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Galderma

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Galderma in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Galderma in 2026.

Incident Types Galderma vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Galderma in 2026.

Incident History - Galderma (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Galderma Subsidiaries

Parent Company

Galderma

Pharmaceutical Manufacturing

Website: http://www.galderma.com

Company Size: 5,001-10,000 employees

No subsidiary data available for this company.

Loading…

Galderma Similar Companies

Dr. Reddy's Laboratories

drreddys.com

Established in 1984, we are a global pharmaceutical company headquartered in Hyderabad, India. Driven by our purpose of ‘Good Health Can’t Wait’, we work to provide access to affordable and innovative medicines. We offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Our major markets include USA, India, Russia & CIS countries, China, Brazil and Europe. As a company with a history of deep science that has led to several industry firsts, we continue to plan ahead and invest in future growth drivers such as access to novel molecules, digital therapeutics and consumer healthcare. As an early adopter of sustainability and ESG actions, we released our first Sustainability Report in 2004. Our current ESG goals aim to set the bar high in environmental stewardship; access and affordability for patients; diversity; and governance. For more information, log on to: www.drreddys.com. Caution Notice: Dr. Reddy's has been made aware of candidates receiving fraudulent job opportunities from unauthorised recruiting agencies or people impersonating Dr. Reddy's leaders. These fraudulent jobs may be advertised on employment sites or mimic our careers site and company email addresses. Please know that Dr. Reddy's Laboratories has no affiliation or connection to these situations. Dr. Reddy's (and its associated/group companies) follows a formal recruitment process through its own HR department. Please report immediately in case you suspect a fraudulent job. You may raise your concern by: Accessing https://drreddys.ethicspoint.com. Calling on the hotline number. List of hotline numbers are available in https://drreddys.ethicspoint.com. The hotline is available 24x7 in multiple languages. Writing to [email protected] or [email protected]. For our community guidelines on LinkedIn, please visit: https://shorturl.at/LTvNZ

Astellas Pharma

astellas.com

Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases with high unmet medical need. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines

Cipla

cipla.com

Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the years. Our credo and our purpose of ‘Caring for Life' continues to guide our actions towards our people and the planet for creating a sustainable future. Cipla today has presence in 80+ countries, providing over 1,500 products across various therapeutic categories in 50+ dosage forms. Keeping with our legacy of care, we constantly strive to ensure access to high-quality medicines that make a difference in the lives of patients. Our paradigm-changing offer of a triple anti-retroviral (ARV) therapy in HIV/AIDS at less than a dollar a day in Africa in 2001 was pivotal in bringing inclusiveness, accessibility and affordability to the centre of the HIV movement. An unmatched presence across the care continuum (awareness, prevention, diagnosis, treatment and adherence) and the widest range of drug-device combinations has established Cipla’s respiratory leadership in India and other key emerging markets. Armed with this legacy and a deep understanding of the lungs, we have articulated our aspiration to become a global lung leader and help millions breathe free.

AUROBINDO PHARMA LTD

aurobindo.com

Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, branded specialty drugs, and active pharmaceutical ingredients (APIs) across more than 150 countries. It is ranked among the top 10 generic companies in eight European nations and holds the distinction of being the largest generic pharmaceutical company in the United States. With over 30 state-of-the-art manufacturing and packaging facilities approved by leading global regulatory authorities including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, and Brazil ANVISA, Aurobindo Pharma ensures the highest standards of quality. Its robust portfolio spans eight major therapeutic areas: Central Nervous System (CNS), Antiretroviral (ARV), Cardiovascular (CVS), Antibiotics, Gastroenterology, Anti-diabetics, Oncology, and Dermatology, supported by a strong R&D infrastructure that drives innovation, affordability, and accessibility.

UCB

cb ucb.com

At UCB, we believe everyone deserves to live the best life they can - as free as possible from the challenges and uncertainty of disease. Our purpose is to support people living with severe central nervous system and immunological conditions by delivering meaningful solutions that go beyond medicine. We are driven by the experiences of patients and caregivers, and inspired to pursue innovations that create real value - not just in clinical outcomes, but in everyday moments, dreams pursued, and simple pleasures enjoyed. Our ambition is to unlock transformative science and technologies that respond to unmet needs and elevate lives. From our headquarters in Belgium to nearly 40 countries around the world, we nurture a culture of respect and care. By listening deeply and collaborating across borders and disciplines, we enable cutting-edge research shaped by patients’ needs. Through strong connections with healthcare professionals, partners, and communities, we strive to make a lasting impact - today and into the future. We're inspired by patients, driven by science.

MANKIND PHARMA LTD

mankindpharma.com

Mankind Pharma, one of the top 5 leading pharmaceutical companies in India, started its journey in 1995. Today, we have an employee base of over 20,000 and are racing towards $1 Billion. At Mankind, we aspire to aid the community in leading a healthy life by formulating, developing, commercializing, and delivering affordable and accessible medicines that satisfy urgent medical needs. We take great pride in the success of our products ranging from Pharma, OTC and FMCG brands like Manforce Condoms, Manforce Tablets, Manforce Staylong Gel, Unwanted 72, Prega News, Gas-O-Fast, Kaloree 1, Kabzend, Acne Star Gel and many others. Our operations are in 34 overseas destinations across Asia, Africa, South-East Asia, Gulf countries and CIS countries. Our Vision - To be a global pharmaceutical company, most admired for its Affordability, Quality and Accessibility of products. Our Mission - To be able to provide cost-effective, innovation based superior quality pharmaceutical products across the globe, to improve the lives of the patients. Mankind strongly believes and follows its Core Values: 𝐂𝐮𝐬𝐭𝐨𝐦𝐞𝐫 𝐂𝐞𝐧𝐭𝐫𝐢𝐜𝐢𝐭𝐲: Commitment to Customer - Internal and External 𝐐𝐮𝐚𝐥𝐢𝐭𝐲: It is in our DNA to maintain and deliver highest quality standards and products 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧: Intensely Research driven organization aiming at product innovation and technology improvements 𝐈𝐧𝐭𝐞𝐠𝐫𝐢𝐭𝐲: Always trustworthy, widely respected to be honest, and believed by everyone 𝐆𝐨 𝐁𝐞𝐲𝐨𝐧𝐝: Aim higher than capabilities 𝐏𝐞𝐨𝐩𝐥𝐞 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐚𝐧𝐝 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧: Together we are foreseeing future and diligently stimulating our people in attaining goals

Lupin

lupin.com

Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position in India and the U.S. across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women’s health. Lupin has 15 state-of-the-art manufacturing sites and 7 research centers globally, along with a dedicated workforce of over 23,000 professionals. Lupin is committed to improving patient health outcomes through its subsidiaries – Lupin Diagnostics, Lupin Digital Health, and Lupin Manufacturing Solutions.

Novartis

cb novartis.com

Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki

SUN PHARMA

sunpharma.com

Sun Pharma is the world's fourth-largest speciality generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma's global presence is supported by more than 40 manufacturing facilities spread across 5 continents, R&D centres across the globe, and a multicultural workforce comprising over 50 nationalities. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities comprising around 3,000 scientists and R&D investments of over 6-8% of annual revenues. At Sun, our people are our greatest asset. Ours has never been a story of individual brilliance but of cultivating a culture of realising collective potential. In our journey, everyone is enabled to take charge in an environment that offers limitless growth opportunities. We are with you every step of the way, so you can shine for years to come. With the launch of our Employee Value Proposition (EVP), we define our promise to ‘Create Your Own Sunshine'—driven by the three pillars of Better Every Day, Take Charge, and Thrive Together. These pillars drive progress at Sun so that people can achieve what they would have thought impossible. Learn more about our EVP here: https://sunpharma.com/careers/

Loading…

NEWS

Galderma CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

October 04, 2025 07:00 AM

Galderma India taps Rohit Sharma and Ritika Sajdeh to champion Cetaphil Baby

Galderma has announced the appointment of Rohit Sharma and Ritika Sajdeh as brand ambassadors for its baby skincare line, Cetaphil Baby.

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-66064

SUMMARY

goshs is a feature-rich single-binary file server for red teamers and developers. Prior to 2.1.5, the httpserver/handler.go sendFile handler opened files using a cleaned path but derived the authorization filename from raw req.URL.Path, so a trailing slash could bypass .goshs ACL-file protection and block-list checks. This issue is fixed in version 2.1.5.

Published

Date2026-07-28

Updated

Date2026-07-28

RISK INFORMATION (Score: 5.3)

cvss3

Base Score: 5.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N

Impact Score

1.4

Exploitability

3.9

REFERENCES

CVE-2026-66063

SUMMARY

goshs is a feature-rich single-binary file server for red teamers and developers. Prior to 2.1.5, the httpserver/updown.go multipart upload handler split part.FileName() on / but did not reject .., allowing an unauthenticated upload with filename .. to create a file outside the served tree. This issue is fixed in version 2.1.5.

Published

Date2026-07-28

Updated

Date2026-07-28

RISK INFORMATION (Score: 6.5)

cvss3

Base Score: 6.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N

Impact Score

2.5

Exploitability

3.9

REFERENCES

CVE-2026-64863

SUMMARY

goshs is a feature-rich single-binary file server for red teamers and developers. Prior to 2.1.4, the httpserver/server.go wdGuard handled WebDAV MOVE as a write-only method and did not enforce --no-delete, allowing WebDAV clients to delete or overwrite files via MOVE with Overwrite: T. This issue is fixed in version 2.1.4.

Published

Date2026-07-28

Updated

Date2026-07-28

RISK INFORMATION (Score: 9.1)

cvss3

Base Score: 9.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:H/A:H

Impact Score

5.2

Exploitability

3.9

REFERENCES

CVE-2026-62325

SUMMARY

goshs is a feature-rich single-binary file server for red teamers and developers. From 2.1.3 until 2.1.4, the sftpserver/sftpserver.go password handler used Username != "" && Password != "", so running goshs with -b 'admin:' -sftp and no -fkf left both SFTP authentication handlers unset and allowed unauthenticated file access. This issue is fixed in version 2.1.4.

Published

Date2026-07-28

Updated

Date2026-07-28

RISK INFORMATION (Score: 9.1)

cvss3

Base Score: 9.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N

Impact Score

5.2

Exploitability

3.9

REFERENCES

CVE-2026-59921

SUMMARY

Netty is an asynchronous, event-driven network application framework. Prior to versions 4.1.136.Final and 4.2.16.Final, HttpPostRequestEncoder constructs multipart HTTP request bodies by directly concatenating user-supplied filenames and field names into Content-Disposition MIME headers without validating or sanitizing CRLF characters (\r\n). Since MIME headers are delimited by CRLF, an attacker who controls the filename can inject arbitrary MIME headers into the multipart body part. The root cause is that neither the encoder nor the FileUpload implementations' setFilename() methods, which only check for null, neutralize CRLF characters before the filename is embedded into the header. This issue has been fixed in versions 4.1.136.Final and 4.2.16.Final.

Published

Date2026-07-28

Updated

Date2026-07-28

RISK INFORMATION (Score: 5.7)

cvss3

Base Score: 5.7

Complexity: LOW

CVSS:3.1/AV:A/AC:L/PR:L/UI:N/S:U/C:N/I:H/A:N

Impact Score

3.6

Exploitability

2.1

REFERENCES

https://github.com/netty/netty/security/advisories/GHSA-gcjf-9mgh-3p7g

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…